
Jonathan Emms, the new president of the ABPI, is a man not shy about defending the rights of the UK …

Jonathan Emms, UK managing director of Pfizer, has taken up his appointment as president of the ABPI, after his election …

The UK healthcare system is at risk of failing to adopt new, personalised medicines and must be willing to pay …

You’d be forgiven for thinking that Deepak Khanna, the man who has overseen the activities of the ABPI for the …

Merck Sharp & Dohme has confirmed that Mike Nally will succeed Deepak Khanna as managing director for MSD in the …

The UK government has announced that the PPRS pricing scheme will largely remain intact, but will have a curb put …

As the ABPI prepares to negotiate a new pricing scheme for the first time in 50 years, its new president …

Pharma’s use of digital media is posing questions that can’t yet be answered, says the new ABPI president Deepak Khanna. …

Deepak Khanna, senior vice president and UK managing director of Merck, Sharp and Dohme has been named as president-elect of …

Merck Sharp and Dohme’s UK managing director Deepak Khanna has been appointed chairman of the American Pharmaceutical Group. The APG …